Preferred Label : capivasertib;

MeSH note : structure in first source;

MeSH synonym : 4-amino-N-(1-(4-chlorophenyl)-3-hydroxypropyl)-1-(7H-pyrrolo(2,3-d)pyrimidin-4-yl)piperidine-4-carboxamide;

Is substance : O;

UNII : WFR23M21IE;

Details


Main resources

You can consult :


https://www.ema.europa.eu/en/medicines/human/EPAR/truqap
2025
false
false
false
Netherlands
French
English
syndication feed
summary of product characteristics
package leaflet
drug evaluation
treatment outcome
capivasertib
capivasertib
capivasertib
drug approval
europe
adult
breast neoplasms
neoplasm metastasis
neoplasm recurrence, local
Locally Advanced Estrogen Receptor-Positive Breast Carcinoma
Metastatic Estrogen Receptor-Positive Breast Carcinoma
Refractory HER2-Negative Breast Carcinoma
Recurrent Estrogen Receptor-Positive Breast Carcinoma
PIK3CA Gene Alteration Positive
AKT1 Gene Alteration Positive
PTEN Gene Alteration Positive
antineoplastic combined chemotherapy protocols
Fulvestrant
Capivasertib/Fulvestrant Regimen
antineoplastic agents
antineoplastic agents
administration, oral
risk management
product surveillance, postmarketing
drug interactions
pregnancy
breast feeding
Female of Childbearing Potential
AKT Inhibitor
AKT Inhibitor
proto-oncogene proteins c-akt
Proto-Oncogene proteins c-akt3
Proto-Oncogene proteins c-akt2
Proto-Oncogene proteins c-akt1
drug evaluation, preclinical

---
https://www.has-sante.fr/jcms/p_3521945/fr/truqap-capivasertib-cancer-du-sein
2024
false
false
false
France
evaluation of the transparency committee
Capivasertib
capivasertib
capivasertib

---
https://ansm.sante.fr/tableau-acces-derogatoire/truqap
https://ansm.sante.fr/actualites/avis-de-lansm-du-07-05-2024-sur-le-medicament-truqap-160-mg-200-mg-comprimes-pellicules-dans-le-cadre-dune-demande-daap
2024
false
false
false
France
French
capivasertib
drug information

---
Nous contacter.
14/06/2025


[Home] [Top]

© Rouen University Hospital. Any partial or total use of this material must mention the source.